Recent Finacing
Recent Raise
ErVimmune is a Lyon-based biotech developing therapeutic cancer vaccines and cell therapies that target cold tumors using antigens derived from human endogenous retroviruses (HERVs).
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at ErVimmune.
